The Federal Drug Administration (FDA) has approved a new once-daily weight-loss pill from Eli Lilly, adding to the bevy of GLP-1 medications available in the consumer marketplace. The drug manufacturer announced on Tuesday that the company would begin shipping orforglipron, branded as Foundayo, as soon as Monday following approval from federal regulators. Prescribed as a…
FDA grants speedy approval to Eli Lilly weight-loss pill
Originally reported by The Hill
Related Articles
Bondi Is Vulnerable as Republican Frustrations Over DOJ’s Epstein Files Missteps Grow
Attorney General Pam Bondi’s critics inside and outside the administration say she has made unforced errors that have tu...
Immigrant Families Are Cautiously Hopeful Over Supreme Court Birthright Citizenship Case
As the high court heard arguments on whether to limit birthright citizenship, many people pondered what the decision cou...
Trump-Backed Candidate in Louisiana Primary Also Praised DEI. Will It Hurt Her?
Representative Julia Letlow of Louisiana, running to challenge Senator Bill Cassidy, is facing conservative blowback ove...
Gorsuch asks Sauer if Native Americans are birthright citizens
Solicitor General D. John Sauer seemed to struggle when pressed by Supreme Court Justice Neil Gorsuch on Wednesday on wh...